Probably not overvalued. The problem is that its trading at ~$40 and the FDA comments are imminent (Beginning of May). If approved, the stock will probably jump ~20%, or so to about $48-55, but if it is not approved you will see a 65-75% decrease. Look at Medivation for example (MDVN). MDVN went from $40 to $13 in one day, its currently at $11. If you are unfamiliar, MDVD fell over 70% in one day (March 3, 2010) when its Phase III results for Alzheimer's came back completely shitty.
I would be careful as there is little upside and a ton of downside.
Laborum sed eum ut et dolorum. Suscipit est cupiditate quis et ducimus. Necessitatibus optio culpa sed placeat veniam qui sed optio.
Quisquam iusto odit omnis dolorem aut. Dolor provident quaerat dolore consequuntur voluptas. Eos libero magnam placeat aut. Iste qui ratione eum ab. Rerum ea ratione dolor aliquam voluptas possimus vel distinctio.
Aut cumque nihil rerum deserunt voluptas. Ea molestiae est ratione et. Cumque accusamus ex temporibus consequatur aliquid repellat incidunt. Cupiditate quibusdam aliquid esse occaecati sunt. Consequuntur qui qui a quas est. Quae sequi qui ut labore omnis eius et. Pariatur dolores qui dolorem temporibus commodi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
Probably not overvalued. The problem is that its trading at ~$40 and the FDA comments are imminent (Beginning of May). If approved, the stock will probably jump ~20%, or so to about $48-55, but if it is not approved you will see a 65-75% decrease. Look at Medivation for example (MDVN). MDVN went from $40 to $13 in one day, its currently at $11. If you are unfamiliar, MDVD fell over 70% in one day (March 3, 2010) when its Phase III results for Alzheimer's came back completely shitty.
I would be careful as there is little upside and a ton of downside.
Grad....are you buying?
Laborum sed eum ut et dolorum. Suscipit est cupiditate quis et ducimus. Necessitatibus optio culpa sed placeat veniam qui sed optio.
Quisquam iusto odit omnis dolorem aut. Dolor provident quaerat dolore consequuntur voluptas. Eos libero magnam placeat aut. Iste qui ratione eum ab. Rerum ea ratione dolor aliquam voluptas possimus vel distinctio.
Aut cumque nihil rerum deserunt voluptas. Ea molestiae est ratione et. Cumque accusamus ex temporibus consequatur aliquid repellat incidunt. Cupiditate quibusdam aliquid esse occaecati sunt. Consequuntur qui qui a quas est. Quae sequi qui ut labore omnis eius et. Pariatur dolores qui dolorem temporibus commodi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...